Molecular stability of a vaccine strain of Canine coronavirus after serial passages in A72 cells
Canine coronavirus (CCoV) exists in types I and II and infects dogs leading mainly to enteritis, though type II has already been associated with generalized and highly lethal infection. A CCoV-type II inactivated vaccine produced in A72 canine cells is available worldwide and largely used, though the molecular stability after serial passages of vaccine seeds is unknown. This article reports the evolution of the CCoV-II vaccine strain 1-71 in A72 cells based on partial S gene sequencing, showing the predominance of neutral evolution and the occurrence of four sites under purifying selection. Thus, cell-adapted strains of CCoV-II may be genetically stable after serial passages in a same cell line due to a stable virus-host relationship.
All journal content is authorized under a Creative Commons (attribution BY-NC type) license. This license lets others remix, adapt, and create works derived of your study, but its commercial use is prohibited. The new works should mention your name in the credits and also cannot be used commercially. However, the derivative works need not be licensed under the same terms of this license.